Drugs / BNP
last change Feb 2016 re-read 3 minutes ago

BNP

Peptide

Developed for
diastolic heart failure

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1/2 NCT00405548 Comparator Mar 2008 → Apr 2011 diastolic heart failure Mayo Clinic Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as BNP ClinicalTrials.gov intervention name — accepted as the source's own label NCT00405548 ↗
Action Restore “cardiac hormone replacement with SQ (subcutaneous or under the skin) injection of BNP” NCT00405548 ↗
Modality Peptide “Chronic Peptide Therapy With B-Type Natriuretic Peptide” PMID 26874387 ↗ Feb 2016
Route Subcutaneous “given subcutaneously” NCT00405548 ↗